… of PD-L1:PD-1 blockade for the treatment of recurrent/metastatic squamous cell carcinoma
… In this review we will explore what is known about the interactions between PD-1 and PD-L1…

… and malignant cells with a particular focus on epithelial cells and squamous cell
carcinoma (SCC), and we discuss intrinsic and extrinsic regulation of PD-L1 expression. …

… the prognostic role of PD-L1 in clear cell carcinoma, while one only included patients with
non-clear cell histology. Five studies used the IHC assay to evaluate PD-L1 expression (1141 …

… /5 (20%) of collecting duct carcinoma. PD-L1 positivity (PD-L1+) in tumor cells was significantly
… On the other hand, PD-L1 positivity by TIMC was observed in 57 (56.4%) patients: 13/36 (…

… (anti-PD-1) in a patient with metastatic PD-L1 (+) basal cell carcinoma, whose disease had
… for testing anti-PD-1 therapy in patients with advanced basal cell carcinoma, either as initial …

… 1 (PD-1)–programmed death ligand-1 (PD-L1) axis have antitumor activity against multiple
cancers. The presence of sarcomatoid differentiation in renal cell carcinoma (… the PD-1/PD-L1 …

… 1 (PD-L1) tumoral expression could potentially be a useful predictive marker. Data reporting
the prevalence of PD-L1 … We sought to determine the frequency of PD-L1 expression in …

… studies with anti-PD-1(BMS-936558) and anti-PD-L1 (BMS-… renal cell carcinoma, melanoma,
and non–small cell lung cancer, and again a relationship between tumor cell surface PD-L1 …

… In the present study, expression of PD-L1 and PD-1 was evaluated by … -negative oral
squamous cell carcinomas and associated nodal metastasis. In addition, CD274/PD-L1 gene copy …

… PD-L1 expression in primary clear-cell renal cell carcinoma (ccRCC) increases the likelihood
of response to anti–PD… We hypothesized that PD-L1 levels assessed in randomly selected …